| Literature DB >> 29258233 |
Maria De Mieri1, Martin Smieško2, Isidor Ismajili3, Marcel Kaiser4,5, Matthias Hamburger6.
Abstract
The acid-induced rearrangement of three epoxyderivatives of nobilin 1, the most abundant sesquiterpene lactone in Anthemisnobilis flowers, was investigated. From the 1,10-epoxyderivative 2, furanoheliangolide 5 was obtained, while the 4,5-epoxy group of 3 did not react. Conversely, when the 3-hydroxy function of nobilin was acetylated (12), the 4,5-epoxy derivative did cyclize into cadinanes (15 and 16) under Lewis acid catalysis. The reactivity of the 4,5- and 1,10-epoxy derivatives of nobilin (2 and 3) was compared with that of parthenolide, and rationalized on the basis of quantum chemical calculations. All isolated reaction products were fully characterized by spectroscopic and computational methods, and their in vitro anti-protozoal activity was evaluated. The paper could provide new insights into the biosynthesis of this class of natural products.Entities:
Keywords: acid-catalyzed rearrangement; anti-protozoal activity; epoxygermacranolides; mechanism of reaction; sesquiterpene lactones
Mesh:
Substances:
Year: 2017 PMID: 29258233 PMCID: PMC6149915 DOI: 10.3390/molecules22122252
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Structures of nobilin 1 and epoxy derivatives 2–4. The carbon numbering follows the semi-systematic nomenclature of sesquiterpenes.
Scheme 2Reactivity of 2 with acids.
1H-NMR spectroscopic data for compounds 5–10 (CD3OD for 5–9, CDCl3 for 10; 500.13 MHz; δ in ppm).
| Position | 5 δH
| 6 δH
| 7 δH
| 8 δH
| 9 b δH
| 10 δH
|
|---|---|---|---|---|---|---|
| 1 | 3.85 (br d, 4.6) | 4.05 (dd, 10.6, 6.5) | 4.96 (dd, 10.2, 3.0) | 3.90 (d, 4.3) | 3.96 (dd, 5.2, 1.4) | 6.22 (d, 5.7) |
| 2 | 2.32–2.20 a | 1.94 a | 2.03 (ddd, 14.5, 3.8, 3.0) | 2.12 (dd, 13.8, 6.8) | 1.82 (ddd, 13.2, 6.2, 1.4) | 5.89 (d, 5.7) |
| 3 | 4.79 (dd, 8.6, 8.3) | 4.49 a | 4.49 a | 4.63 (dd, 11.0, 6.8) | 4.22 (dd, 11.4, 6.2) | - |
| 4 | - | - | - | - | - | - |
| 5 | 5.26 (dq, 7.2, 1.5) | 5.27 (dq, 10.5, 1.5) | 5.39 (dq, 10.5, 1.5) | 3.06 (d, 7.3) | 4.79 (br s) | 5.48 (dq, 5.8, 1.2) |
| 6 | 6.14 a | 6.00 (dd, 10.5, 9.5) | 6.38 (dd, 10.5, 9.2) | 5.25 (dd, 7.3, 5.5) | 5.63 (br d, 5.7) | 5.95 (ddq, 5.8, 5.2, 1.2) |
| 7 | 3.08 (dddd, 9.0, 7.5, 3.0, 3.0) | 3.09 (dddd, 9.5, 9.5, 3.5, 3.0) | 3.02 (dddd, 9.5, 9.2, 3.5, 3.0) | 3.35 (dddd, 9.0, 5.5, 2.6, 2.5) | 3.31 (m) | 3.26 (dddd, 10.5, 5.2, 2.8, 2.5) |
| 8 | 5.33 (dd, 9.5, 9.0) | 5.57 (dd, 10.2, 9.5) | 6.00 (dd, 10.5, 9.5) | 5.00 (dd, 9.8, 9.0) | 5.06 (ddd, 10.0, 6.9, 1.2) | 5.17 (ddd, 10.5, 5.0, 3.2) |
| 9 | 2.09 (dd, 14.8, 9.5) | 5.18 (dq, 10.2, 1.5) | 5.30 (dq, 10.5, 1.5) | 1.87 a β | 1.91 a | 2.14 (dd, 15.4, 5.0) |
| 10 | - | - | - | - | - | - |
| 11 | - | - | - | - | - | - |
| 12 | - | - | - | - | - | - |
| 13 | 5.65 (dd, 3.0, 0.7) | 5.71 (d, 3.0) | 5.85 (d, 3.0) | 5.74 (br d, 2.5) | 5.41 (br d, 2.5) | 5.89 (br d, 2.5) |
| 14 | 1.49 (s) | 1.95 (d, 1.5) | 1.80 (d, 1.5) | 1.37 (br s) | 1.33 (s) | 1.53 (s) |
| 15 | 1.66 (br s) | 1.76 (d, 1.5) | 1.79 (d, 1.5) | 1.27 (s) | 1.18 (br s) | 1.73 (t, 1.2) |
| 1′ | - | - | - | - | - | - |
| 2′ | - | - | - | - | - | - |
| 3′ | 6.17 (qq, 7.0, 1.5) | 6.20 (qq, 7.0, 1.5) | 6.20 (qq, 7.0, 1.5) | 6.16 (qq, 7.0, 1.5) | 6.15 (br q, 7.2) | 6.16 (br q, 7.2) |
| 4′ | 1.96 (dq, 7.0, 1.5) | 1.95 (dq 7.0, 1.5) | 1.98 (dq 7.0, 1.5) | 1.94 (dq 7.0, 1.5) | 1.91 (br d, 7.2) | 2.00 (br d, 7.2) |
| 5′ | 1.89 (quint, 1.5) | 1.89 (quint, 1.5) | 1.91 (quint, 1.5) | 1.88 (quint, 1.5) | 1.84 (quint, 1.5) | 1.91 (quint, 1.5) |
a Overlapped signals; b p-toluenesulphonate group: H-2, H-2′ δH = 7.76 pseudo d, J = 8.3 Hz; H-3, H-3′ δH = 7.41 pseudo d, J = 8.3 Hz; -CH δH = 2.45, s.
13C-NMR spectroscopic data for compounds 5–8 (CD3OD for 5–9, CDCl3 for 10; 125.77 MHz; δ in ppm).
| Position | 5 δC | 6 δC | 7 δC a | 8 δC | 9 δC c | 10 δC a |
|---|---|---|---|---|---|---|
| 1 | 77.6, CH | 76.2, CH | 69.4, CH | 77.9, CH | 78.8, CH | 139.3, CH |
| 2 | 41.8, CH2 | 38.9, CH2 | 37.0, CH2 | 39.0, CH2 | 36.6, CH2 | 128.3, CH |
| 3 | 81.7, CH | 74.1, CH | 74.9, CH | 78.6, CH | 85.3, CH | 110.4, C |
| 4 | 141.9, C | 142.2, C | 145.9, C | 66.2, C | 75.2, C | 137.8, C |
| 5 | 124.0, CH | 126.7, CH | 125.5, CH | 68.7, CH | 89.3, CH | 129.6, CH |
| 6 | 78.5, CH | 76.8, CH | 78.0, CH | 82.7, CH | 82.5, CH | 76.4, CH |
| 7 | 52.2, CH | 50.9, CH | 52.1, CH | 49.09, CH | 48.0, CH | 48.2, CH |
| 8 | 74.1, CH | 74.0, CH | 72.5, CH | 73.3, CH | 74.0, CH | 71.5, CH |
| 9 | 46.8, CH2 | 126.8, CH | 121.9, CH | 49.15, CH2 | 49.3, CH2 | 42.9, CH2 |
| 10 | 87.3, C | 143.2, C | 144.1, C | 87.1, C | 85.8, C | 87.3, C |
| 11 | 139.0, C | 140.1, C | 140.0, C | 137.2, C | 137.1, C | 137.7, C |
| 12 | 171.8, C | 172.0, C | 172.0, C | 171.7, C | 171.3, C | 169.6, C |
| 13 | 124.8, CH2 | 121.8, CH2 | 121.8, CH2 | 127.0, CH2 | 125.5, CH2 | 123.8, CH2 |
| 14 | 19.6, CH3 | 11.7, CH3 | 19.5, CH3 | 20.7, CH3 | 22.6, CH3 | 28.0, CH3 |
| 15 | 20.2, CH3 | 22.8, CH3 | 23.6, CH3 | 20.5 b, CH3 | 24.2, CH3 | 20.2, CH3 |
| 1′ | 167.9, C | 168.2, C | 168.2, C | 168.0, C | 168.3, C | 167.4, C |
| 2′ | 128.7, C | 128.7, C | 128.6, C | 128.7, C | 127.0, C | 126.2, C |
| 3′ | 140.4, CH | 139.9, CH | 140.0, CH | 14.03, CH | 140.3, CH | 139.4, CH |
| 4′ | 16.1, CH3 | 16.0, CH3 | 16.0, CH3 | 16.0, CH3 | 16.0, CH3 | 15.7, CH3 |
| 5′ | 20.7, CH3 | 20.8, CH3 | 20.9, CH3 | 20.6 b, CH3 | 20.5, CH3 | 20.6, CH3 |
a Extracted from 1H-13C 2D inverse detected experiments due to low amount of sample; b interchangeable within the same column; c p-toluensulphonate group: C-1 (134.7), C-2/C-2′ (129.0), C-3/C-3′ (131.4), C-4 (147.2), -CH3 (21.6).
Scheme 3Reactivity of 4 with acids.
Scheme 4Reactivity of 11 and 12 with acids.
1H-NMR spectroscopic data for compounds 13–16 (CD3OD; 500.13 MHz; δ in ppm).
| Position | 13 δH (mult, | 14 δH (mult, | 15 δH (mult, | 16 δH (mult, |
|---|---|---|---|---|
| 1 | 4.11 (dd, 10.6, 6.5) | 4.01 (dd, 11.7, 3.0) | - | - |
| 2 | 1.91 a | 2.17 a (ddd, 15.0, 5.0, 3.0) | 6.65 (s) | 7.91 (d, 8.5) |
| 3 | 5.49 (br d, 6.0) | 5.30 a | - | 7.34 (br d, 8.5) |
| 4 | - | - | - | - |
| 5 | 5.32 (dq, 8.5, 1.2) | 5.32 (dq, 10.3, 1.2) | 6.65 (s) | 7.58 (br s) |
| 6 | 5.28 a | 5.87 (dd, 10.3, 2.0) | - | - |
| 7 | 3.17 (dddd, 9.5, 8.5, 3.5, 3.0) | 3.20 (dddd, 10.7, 2.0, 1.7, 1.5) | 3.97 (d, 5.8) | - |
| 8 | 5.65 (dd, 10.5, 9.5) | 5.03 (td, 10.5, 4.0) | 5.50 (ddd, 7.5, 5.7, 2.7) | 7.19 (d, 7.2) |
| 9 | 5.24 (dq, 10.5, 1.2) | 2.49 a | 1.80 a | 7.20 (d, 7.2) |
| 10 | - | - | 3.97 (sextet, 7.0) | - |
| 11 | - | - | - | - |
| 12 | - | - | - | - |
| 13 | 5.74 (d, 3.0) | 5.75 (d, 1.5) | 5.31 (br s) | 5.74 (d, 1.8) |
| 6.17 (d, 3.5) | 6.23 (d, 1.7) | 6.33 (br s) | 6.51 (d, 1.8) | |
| 14 | 1.97 (d, 1.2) | 5.48 (br s) | 1.34 (d, 7.0) | 2.65 (s) |
| 15 | 1.85 (d, 1.2) | 1.85 (d, 1.2) | 2.10 (s) | 2.46 (br s) |
| 1′ | - | - | - | - |
| 2′ | - | - | - | - |
| 3′ | 6.19 (qq, 7.0, 1.5) | 6.15 (qq, 7.0, 1.5) | 6.03 (qq, 7.0, 1.5) | - |
| 4′ | 1.99 (dq, 7.0, 1.5) | 1.96 (dq, 7.0, 1.5) | 1.81 (dq, 7.0, 1.5) | - |
| 5′ | 1.92 (quint, 1.5) | 1.90 (quint, 1.5) | 1.79 (quint, 1.5) | - |
| 1″ | - | - | - | - |
| 2″ | 2.02, (s) | 2.04, (s) | - | - |
a Overlapped signals.
13C-NMR spectroscopic data for compounds 13–16 (CD3OD; 125.77 MHz; δ in ppm).
| Position | 13 δC a | 14 δC a | 15 a δC | 16 a δC |
|---|---|---|---|---|
| 1 | 75.4, CH | 70.6, CH | 140.5, C | 132.5, C |
| 2 | 35.2, CH2 | 34.5, CH2 | 113.9, CH | 125.0, CH |
| 3 | 74.6, CH | 73.6, CH | 155.0, C | 128.4, CH |
| 4 | 137.9, C | 139.4, C | 124.0, C | 136.4, C |
| 5 | 127.0, CH | 124.8, CH | 132.0, CH | 126.1, CH |
| 6 | 76.0, CH | 75.0, CH | 126.6, C | 128.6, CH |
| 7 | 50.0, CH | 49.1, CH | 48.3, CH | 135.60, C |
| 8 | 72.8, CH | 73.6, CH | 71.9, CH | 127.4, CH |
| 9 | 127.6, CH | 39.8, CH2 | 33.6, CH2 | 126.0, CH |
| 10 | 141.7, C | 144.4, C | 31.5, CH | 135.4, C |
| 11 | 139.0, C | 135.2, C | 145.1, C | 145.5, C |
| 12 | 170.8, C | 170.0, C | 170.1, C | 171.8, C |
| 13 | 121.3, CH2 | 125.7, CH2 | 129.1, CH2 | 127.6, CH2 |
| 14 | 11.1, CH3 | 116.5, CH2 | 22.9, CH3 | 19.4, CH3 |
| 15 | 22.2, CH3 | 21.7, CH3 | 15.6, CH3 | 21.7, CH3 |
| 1′ | 167.6, C | 166.8, C | 169.4, C | - |
| 2′ | 128.0, C | 127.2, C | 129.5, C | - |
| 3′ | 139.5, CH | 138.5, CH | 138.8, CH | - |
| 4′ | 15.6, CH3 | 14.6, CH3 | 15.4, CH3 | - |
| 5′ | 20.3, CH3 | 19.0, CH3 | 20.5, CH3 | - |
| 1″ | 169.2, C | 170.0, C | - | - |
| 2″ | 20.9, CH3 | 19.7, CH3 | - | - |
a Extracted from 1H-13C 2D inverse detected experiments due to low amount of sample.
Figure 1Energy profile of the transformation of 2 into 5. Relative energies are reported in kcal/mol. The hydrogen bonding interaction O-3…H-6 is represented with a dashed line.
Figure 2Energy profile of the putative transannular cyclization of 3. Relative energies are reported in kcal/mol. The hydrogen bonding interaction O-3…H-6 is represented with a dashed line.
Scheme 5Reactivity of 3 and parthenolide with acids.
Figure 3Energy profile of the transformation of parthenolide into micheliolide. Relative energies are reported in kcal/mol.
In vitro activity of compounds 1, 3–8, and 10–15 against T. b. rhodesiense (STIB 900), T. cruzi (Tulahuen C4 LacZ), L. donovani (MHOM-ET-67/L82), P. falciparum (NF54), and cytotoxicity in L6 cells.
| Compound | L6 cells | ||||
|---|---|---|---|---|---|
| 1 | 2.08± 0.09 (2.4) b | 11.3± 3.3 (0.4) b | 2.69± 1.08 (1.8) b | 3.12± 0.52 (1.6) b | 4.91 ± 0.53 |
| 3 | 1.96± 0.16 (2.04) b | 4.24 (0.9) h | 13.19± 3.31 (0.3) b | 2.39 (1.7) h | 4.0 ± 0.03 |
| 4 | 2.18 ± 0.49 (2.6) b | 8.38 (0.7) h | 28.67 ± 8.95 (0.2) b | 3.20 (1.7) h | 5.56 ± 0.30 |
| 5 | 0.91 ± 0.16 (3.7) b | 6.35 (0.5) h | 8.28 ± 2.40 (0.4) b | 4.06 (0.8) h | 3.33 ± 0.28 |
| 6–7 | 1.21 ± 0.16 (3.9) b | 16.00 ± 0.34 (0.3) b | 12.88 ± 0.65 (0.4) b | 13.82 ± 1.59 (0.3) b | 4.74 ± 0.24 |
| 8 | 3.25 ± 0.50 (3.5) b | 47.9 ± 1.11 (0.24) b | 66.8 ± 7.79 (0.17) b | 31.3 ± 2.40 (0.4) b | 11.5 ± 0.72 |
| 10 | 13.4 ± 0.46 (1.51) b | 132.19 ± 0.59 (0.15) b | 35.96 ± 0.18 (0.56) b | 79.13 ± 1.02 (0.26) b | 20.20 ± 2.098 |
| 11 | 1.57 ± 0.005 (0.28) b | 11.49 ± 0.68 (0.2) b | 4.20 ± 0.28 (0.55) b | 3.93 ± 0.53 (0.59) b | 2.31 ± 0.196 |
| 12 | 0.47 ± 0.006 (2.19) b | 2.60 ± 0.69 (0.5) b | 1.30 ± 0.03 (0.79) b | 1.55 ± 0.31 (0.66) b | 1.03 ± 0.076 |
| 13 | 0.54 ± 0.013 (3.46) b | 12.76 ± 1.08 (0.15) b | 3.26 ± 0.22 (0.57) b | 9.17 ± 0.61 (0.20) b | 1.87 ± 0.026 |
| 14 | 1.20 ± 0.151 (4.4) b | 15.4 ± 1.48 (0.6) b | 4.97 ± 0.43 (7.2) b | 8.80 ± 0.94 (0.68) b | 3.95 ± 0.088 |
| 15 | 13.32 ± 0.333 (1.68) b | 36.81 ± 7.76 (0.61) b | 5.86 ± 0.59 (3.83) b | 35.66 ± 1.10 (0.63) b | 22.44 ± 0.157 |
| Positive control | 0.01 ± 0.01 c | 2.0 ± 0.2 d | 0.13 ± 0.01 e | 0.006 ± 0.01 f | 0.016 ± 0.01 g |
a Average of two independent assays in μg/mL; b Selectivity Index (SI): IC50 in L6 cells divided by IC50 in the titled parasitic strain; c melarsoprol; d benznidazole; e miltefosine; f chloroquine; g podophyllotoxin; h one assay.